Thursday, 1 October 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleSeeking Alpha· July 27, 2026

Baker Hughes targets Horizon 2 IET orders above $45B as it forecasts $27.35B 2026 revenue and integrates Chart

View original at seekingalpha.com

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Q3 2026 guidance is company revenue of $6.87 billion and adjusted EBITDA of $1.205 billion, assuming Middle East activity remains broadly unchanged through year-end

    60% confidence
  • Asked about the drivers of record IET orders and margins on recent orders

    60% confidence
  • Baker Hughes is not providing Chart segment guidance today and will provide updated guidance ahead of Q3 earnings

    60% confidence
  • Uncertainty centers on project timing, local supply chains, Gas Tech equipment backlog conversion, and the aeroderivative supply chain; free cash strength reflected milestone and advanced payments, with working capital driving quarter-to-quarter variability

    60% confidence
  • GAAP diluted EPS was $0.68; excluding $0.04 of adjusting items, adjusted diluted EPS was $0.64

    60% confidence
  • OFSE revenue was $3.45 billion, EBITDA $605 million, margin 17.5%, a significantly stronger-than-anticipated quarter despite Middle East disruptions

    60% confidence
  • Data centers are one of the clearest near-term commercial opportunities with Chart, alongside actionable gas infrastructure opportunities across hydrogen, helium, CO2, nitrogen, oxygen, and longer-term adjacencies in space, geothermal and mining

    60% confidence
  • Chart will operate as Baker Hughes' third reporting segment with integration driven through 18 work streams

    60% confidence
  • OFS outperformance came from stronger activity outside the Middle East, better-than-anticipated Middle East product revenue, and SSPS revenue up about 10% sequentially

    60% confidence
  • IET orders doubled year-over-year to a record $7.1 billion with a 2.2x book-to-bill ratio and RPO up 19% to an all-time high of $37.1 billion

    60% confidence
  • Asked what drove OFS outperformance and the moving parts for the second half

    60% confidence
  • Asked about capacity expansion plans through 2029 and implications for mix, pricing, and CapEx

    60% confidence
  • Disciplined execution and diversified portfolio offset anticipated Middle East headwinds

    60% confidence
  • Given longer GTE cycle times, a meaningful portion of the GTE order mix extends beyond 2027

    60% confidence
  • New gas turbine/generator capacity coming online by 2029 could support nearly $5 billion in annual Power Systems revenue opportunity at full utilization

    60% confidence
  • Asked about puts/takes for IET in the second half and why free cash flow conversion was unchanged

    60% confidence
  • The expected $5 billion of annualized revenue capacity by 2029 implies roughly a 3-4x increase versus ~$1 billion last year, with paybacks below 2 years and gas turbines representing roughly half the opportunity

    60% confidence
  • Horizon 2 IET orders are now expected to exceed $45 billion, up from a prior expectation of exceeding $40 billion, supported by $12 billion of IET orders year-to-date

    60% confidence
  • FY2026 revenue and adjusted EBITDA are now expected to modestly exceed prior expectations, guided to $27.35 billion revenue and $4.85 billion adjusted EBITDA

    60% confidence
  • IET revenue was $3.3 billion, EBITDA $678 million, margin 20.6%, driven by favorable backlog pricing and Baker Hughes Business System execution

    60% confidence
  • Following the Chart acquisition, leverage will temporarily increase, with a return to 1-1.5x net leverage expected within 24 months

    60% confidence
  • Adjusted EPS was $0.64 with a record 18.3% adjusted EBITDA margin

    60% confidence
  • Full-year IET orders guidance raised to $17.5-$19.5 billion, with IET revenue midpoint at $13.5 billion (assuming Waygate closes at year-end) and IET EBITDA midpoint of $2.725 billion

    60% confidence
  • Asked about commercial synergies with Chart

    60% confidence
  • Q2 adjusted EBITDA was $1.23 billion, exceeding the high end of guidance

    60% confidence
  • Record IET orders were driven by data centers, LNG, and gas processing, including $2.6 billion of Power Systems orders (~150 gas turbines), with data centers accounting for $2.2 billion of Power Systems orders; pricing discipline supports IET margins in 2027 and beyond

    60% confidence
  • Total company bookings were $10.5 billion with free cash flow of $1.1 billion and net debt to adjusted EBITDA declining to 0.1x

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI-Driven Drug Development Meets Biotech Deal-Making and Regulatory Catalysts
AI-designed therapeutics (Insilico's rentosertib showing biological-age reductions) are moving into the clinical mainstream. Large-cap biotech is simultaneously reallocating capital through M&A (Lilly–Merida, $2.9B) and government funding (BARDA–Basilea), while trial failures (ziltivekimab, a 9.4% Novo Nordisk share drop) and upcoming FDA catalysts (the ivonescimab PDUFA on 2026-11-14) drive volatility. The wider AI regulatory and legal climate (Tesla Cybercab probe, xAI's Minnesota loss, OpenAI suits) is tightening, though QAIAx's micro-cap trial claims are speculative and weakly connected.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,317 source documents archived
Query this data → isubstrate.com